← All indications
Adenoviridae Infections
Virus diseases caused by the ADENOVIRIDAE.
Subtype terms (2)
More specific conditions that are subtypes of Adenoviridae Infections in the MeSH hierarchy.
- Adenovirus Infections, Human
14 drugs (8 approved, 6 experimental)
- Hepatitis, Infectious Canine
Drugs by status
Phase 3 trials (3)
Phase 2 trials (8)
Phase 1 trials (4)
Other trials (1)
Organizations
Organization Involved with Phase 4 Indications (7)
Organization Involved with Phase 3 Indications (7)
Organization Involved with Phase 2 Indications (38)
- Merck
- DNAtrix, Inc.
- ViraCyte
- The EMMES Corporation
- National Heart, Lung, and Blood Institute (NHLBI)
- National Marrow Donor Program
- University of Pennsylvania
- University of Pittsburgh
- Baylor University
- Canadian Cancer Trials Group
- University of London
- Harvard University
- Duke University
- Medical College of Wisconsin
- Nanjing Medical University
- New York Medical College
- Rutgers University
- Shenzhen Geno-Immune Medical Institute
- St. Anna Kinderkrebsforschung
- Sichuan University
- University of Miami
- University of Ottawa
- University of Southern California
- University of Bern
- Xiamen University
- University of California, Los Angeles
- Chengdu Shi Endor Biological Engineering Technology Co., Ltd
- Free University of Amsterdam
- Kuur Therapeutics
- Government of China
- +8 more
Organization Involved with Phase 1 Indications (19)
- PaxVax, Inc.
- Altimmune, Inc.
- Centers for Disease Control and Prevention, China
- National Institute of Allergy and Infectious Diseases (NIAID)
- United States Army
- Case Western Reserve University
- University of Washington
- Henry Ford Health System
- HIV Vaccine Trials Network
- Institut Català d'Oncologia
- McMaster University
- University of Rochester
- Capital Medical University
- University of Alabama, Birmingham
- Canadian Institutes of Health Research (CIHR)
- University of Helsinki
- Chinese Academy of Medical Sciences
- TILT Biotherapeutics Ltd.
- Docrates Cancer Center
Organization Involved with Other Experimental Indications (1)